Oseltamivir drug‐disease modelling in infants with influenza virus infection
Abstract Aims Oseltamivir is a commonly used neuraminidase inhibitor for treatment of influenza infection, but little data exist regarding concentration‐response relationships. Methods Pharmacokinetic (PK) and viral dynamic data from an earlier NIAID Collaborative Antiviral Study Group trial in paediatric patients with influenza from 0–23 months of age
Kun Wang +4 more
wiley +1 more source
In recent years, decarbonization policies have pushed for a significant increase in renewable energies for power generation applications. European strategy aims to bring online over 320 GW of solar photovoltaics by 2025 and almost 600 GW by 2030. In this
Brivio Elisabetta +2 more
doaj +1 more source
The development impact of a best practice seasonal worker policy: New Zealand’s Recognised Seasonal Employer (RSE) Scheme [PDF]
Seasonal migration programs are widely used around the world, and are increasingly seen as offering a potential “triple-win”- benefiting the migrant, sending country, and receiving country.
Gibson, John, McKenzie, David
core
sj-docx-1-rse-10.1177_07419325221102537 – Supplemental material for Improving Numeracy Skills in First Graders with low performance in early numeracy: A Randomized Controlled Trial [PDF]
Supplemental material, sj-docx-1-rse-10.1177_07419325221102537 for Improving Numeracy Skills in First Graders with low performance in early numeracy: A Randomized Controlled Trial by Anita Lopez-Pedersen, Riikka Mononen, Pirjo Aunio, Ronny Scherer and ...
Ronny Scherer (2558542) +4 more
core +1 more source
Abstract Aims Canagliflozin was recently approved in type 2 diabetes mellitus (T2DM) patients ≥10 and <18 years old as a single agent dosed once daily (QD) or in a fixed‐dose combination with metformin dosed twice daily (BID). We characterize canagliflozin pharmacokinetics in paediatric patients with T2DM, compare estimated individual and simulated ...
Nele Goeyvaerts +6 more
wiley +1 more source
Nordic-RSE: Developing an international RSE community
This presentation was produced for the CodeRefinery project that was supported by the Nordic e-Infrastructure Collaboration (NeIC), which is part of NordForsk.
openaire +1 more source
sj-docx-1-rse-10.1177_07419325231193332 – Supplemental material for No Child Left Behind and the Individuals with Disabilities Education Act: Examining Special Educators’ Outcomes [PDF]
Supplemental material, sj-docx-1-rse-10.1177_07419325231193332 for No Child Left Behind and the Individuals with Disabilities Education Act: Examining Special Educators’ Outcomes by Tuan D. Nguyen, PhD, Christopher Redding, PhD, Allison F.
Tuan D. Nguyen (1788030) +3 more
core +1 more source
Aim Meropenem is a second‐line antimicrobial agent in the treatment of febrile neutropenia in onco‐haematological patients. A population pharmacokinetic/pharmacodynamic (PK/PD) analysis for assessing the relationship between meropenem exposure and C‐reactive protein (C‐RP) over time was conducted.
Chun Liu +7 more
wiley +1 more source
The Third Sector and the Argentine buisiness world
not available.
Luis Ulla
doaj
sj-docx-1-rse-10.1177_07419325231213876 – Supplemental material for An Extensive Reading Intervention for Emergent Bilingual Students With Significant Reading Difficulties in Middle School [PDF]
Supplemental material, sj-docx-1-rse-10.1177_07419325231213876 for An Extensive Reading Intervention for Emergent Bilingual Students With Significant Reading Difficulties in Middle School by Philip Capin, Jeremy Miciak, Bethany H.
Bethany H. Bhat (17710995) +6 more
core +1 more source

